References
- Hendaus, M. A. (2020). Remdesivir in the treatment of coronavirus disease 2019 (COVID-19): A simplified summary. Journal of Biomolecular Structure & Dynamics, 1–6. https://doi.org/10.1080/07391102.2020.1767691
- Hendaus, M. A., & Jomha, F. A. (2020). From COVID-19 to clot: The involvement of the complement system. Journal of Biomolecular Structure & Dynamics, 1–6. https://doi.org/10.1080/07391102.2020.1832919
- Li, Y., Zhang, Z., Yang, L., Lian, X., Xie, Y., Li, S., Xin, S., Cao, P., & Lu, J. (2020). The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike. iScience, 23(8), 101400. https://doi.org/10.1016/j.isci.2020.101400
- Seyedpour, S., Khodaei, B., Loghman, A. H., Seyedpour, N., Kisomi, M. F., Balibegloo, M., Nezamabadi, S. S., Gholami, B., Saghazadeh, A., & Rezaei, N. (2021). Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies. Journal of Cellular Physiology, 236(4), 2364–2392. https://doi.org/10.1002/jcp.30032
- Strollo, R., & Pozzilli, P. (2020). DPP4 inhibition: Preventing SARS-CoV-2 infection and/or progression of COVID-19? Diabetes/Metabolism Research and Reviews, 36(8), e3330. https://doi.org/10.1002/dmrr.3330